Symrise, DE000SYM9999

Symrise stock holds firm as margins and valuation diverge

Published on 08/26/2026 at 20:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Symrise stock is trading at €71.12 as investors weigh a €9.93 billion market cap, a 19.51 normalized P/E, and trailing revenue of $4.91 billion in recent market data.

Pop-Art-Comic eines Parfümeurs beim Mischen von Duftölen im Labor, Symrise AG DE000SYM9999
Symrise AG (DE000SYM9999) Pop-Art-Comic illustriert Parfümeur beim Mischen bunter Duftöle im Labor dynamisch, Illustration mit AI erstellt.

Shares at a premium

Symrise AG (DE000SYM9999) is trading at €71.12, with a €9.93 billion market value and a 19.51 normalized price-to-earnings ratio in the latest market snapshot on August 26, 2026. The same data puts the shares 659 percent above Morningstar's quantitative fair value estimate of €15.12.

The valuation gap is the main read-through for investors on a day when the broader tape is mixed, and it keeps Symrise in the group of specialty chemical names where profit quality matters more than a simple price move.

Revenue and cash flow

Yahoo Finance's latest Symrise data shows revenue of $4.91 billion, net income of $246.08 million, and diluted earnings per share of $0.51 on a trailing basis as of July 31, 2026. That pairs with a 5.01 percent profit margin, $451.08 million in cash, and $220.95 million in levered free cash flow.

The comparison that stands out is leverage versus earnings power: the same snapshot shows total debt to equity at 60.61 percent, while return on equity is 6.71 percent and return on assets is 4.96 percent. For a specialty ingredients group, that mix keeps margin discipline and cash conversion at the center of the story.

Peer context

Against other specialty chemicals names in the same market data set, Symrise trades at a lower market cap than Givaudan SA at $38.568 billion and DSM Firmenich AG at $26.931 billion, while its 52-week range on the OTC quote runs from $19.31 to $26.91. The stock also changed hands at $26.58 on August 7, 2026 in the quoted OTC line, which is still useful context for the U.S. line of sight.

That gap between scale and valuation explains why the stock tends to react more to margin trends than to broad sector headlines. A 1.39 percent forward yield also adds another measurable layer to the current setup.

Scent and care

Symrise's business still centers on fragrances, flavorings, cosmetic ingredients, and functional solutions for food, personal care, and cleaning products. Those end markets matter because the company's two reporting segments, Taste, Nutrition & Health and Scent & Care, feed directly into revenue mix, margin structure, and cash generation.

For investors, the core product story remains tied to ingredients that travel into consumer goods rather than one-off projects.

Market view

As of August 26, 2026, the shares sit at €71.12 with a day range of €71.08 to €71.16 and a market cap of €9.93 billion. The valuation, cash flow, and peer comparison all point to a stock that is being judged on execution rather than on size alone.

Fact box

Company: Symrise AG

ISIN: DE000SYM9999

Ticker: SY1

Exchange: Xetra

Price (as of August 26, 2026): €71.12

Market cap: €9.93 billion

Sector / Industry: Basic Materials / Specialty Chemicals

Index membership: DAX

Disclaimer...

en | DE000SYM9999 | SYMRISE | boerse | 70005498 | bgmi